DexCom: Dexcom picks longtime Masimo exec as next CCO

Dexcom (Nasdaq:DXCM) announced today that it appointed Jon Coleman as its new chief commercial officer (CCO). Coleman assumes responsibility for Dexcom's global commercial organization, including global sales, marketing and customer experience. He takes over for Teri Lawver, who in October announced her plans to retire as CCO of the continuous glucose monitor (CGM) maker. At [...]The post Dexcom picks longtime Masimo exec as next CCO appeared first on Drug Delivery Business.